Terms: = Lung cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29
151 results:
1. Prognostic value of tumor volume doubling time in lung-metastatic adenoid cystic carcinoma.
Dal Lago EA; Sousa LG; Yang Z; Hoff CO; Bonini F; Sawyer M; Wang K; Lewis W; Wahid KA; Hanna EY; El-Naggar A; Fuller CD; Kundu S; Godoy M; Ferrarotto R
Oral Oncol; 2024 Apr; 151():106759. PubMed ID: 38507991
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB-IIIB lung squamous cell carcinoma.
Liu J; Zhu L; Tang M; Huang X; Gu C; He C; Lv X; Hu J
Sci Rep; 2024 Mar; 14(1):5523. PubMed ID: 38448498
[TBL] [Abstract] [Full Text] [Related]
3. cancer Risk Following Smoking Cessation in Korea.
Park E; Kang HY; Lim MK; Kim B; Oh JK
JAMA Netw Open; 2024 Feb; 7(2):e2354958. PubMed ID: 38319658
[TBL] [Abstract] [Full Text] [Related]
4. Gender differences, environmental pressures, tumor characteristics, and death rate in a lung cancer cohort: a seven-years Bayesian survival analysis using cancer registry data from a contaminated area in Italy.
Mincuzzi A; Carone S; Galluzzo C; Tanzarella M; Lagravinese GM; Bruni A; Rashid I; Bisceglia L; Sardone R; Addabbo F; Minerba S; Giannico OV
Front Public Health; 2023; 11():1278416. PubMed ID: 38269375
[TBL] [Abstract] [Full Text] [Related]
5. Plasma cell-free DNA as a sensitive biomarker for multi-cancer detection and immunotherapy outcomes prediction.
Xu J; Chen H; Fan W; Qiu M; Feng J
J Cancer Res Clin Oncol; 2024 Jan; 150(1):7. PubMed ID: 38196018
[TBL] [Abstract] [Full Text] [Related]
6. Single extracellular vesicle surface protein-based blood assay identifies potential biomarkers for detection and screening of five cancers.
Min Y; Deng W; Yuan H; Zhu D; Zhao R; Zhang P; Xue J; Yuan Z; Zhang T; Jiang Y; Xu K; Wu D; Cai Y; Suo C; Chen X
Mol Oncol; 2024 Mar; 18(3):743-761. PubMed ID: 38194998
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell mass cytometric analysis of peripheral immunity and multiplex plasma marker profiling of non-small cell lung cancer patients receiving PD-1 targeting immune checkpoint inhibitors in comparison with platinum-based chemotherapy.
Neuperger P; Szalontai K; Gémes N; Balog JÁ; Tiszlavicz L; Furák J; Lázár G; Puskás LG; Szebeni GJ
Front Immunol; 2023; 14():1243233. PubMed ID: 37901220
[TBL] [Abstract] [Full Text] [Related]
8.
Xiao L; Yu S; Xu W; Sun Y; Xin J
Korean J Radiol; 2023 Nov; 24(11):1142-1150. PubMed ID: 37899523
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Li A; Liu S; Zhang H; Lin M; Guo L; Yuan C; Li Z; Xu J; Wang T
Medicine (Baltimore); 2023 Oct; 102(40):e35483. PubMed ID: 37800773
[TBL] [Abstract] [Full Text] [Related]
10. Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
Li P; Zhang Y; Xu T; Zhu J; Wei T; Zhao W
Nucl Med Commun; 2023 Dec; 44(12):1114-1125. PubMed ID: 37769014
[TBL] [Abstract] [Full Text] [Related]
11. Bidirectional Association Between Cardiovascular Disease and lung cancer in a Prospective Cohort Study.
Zhang S; Liu L; Shi S; He H; Shen Q; Wang H; Qin S; Chang J; Zhong R
J Thorac Oncol; 2024 Jan; 19(1):80-93. PubMed ID: 37703998
[TBL] [Abstract] [Full Text] [Related]
12. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.
Zhang W; Qu H; Ma X; Li L; Wei Y; Wang Y; Zeng R; Nie Y; Zhang C; Yin K; Zhou F; Yang Z
Front Immunol; 2023; 14():1179742. PubMed ID: 37622116
[TBL] [Abstract] [Full Text] [Related]
13. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
14. Clinical effect of surgical treatment for lung metastasis and prognostic risk factor analysis: a single-centred cohort study.
Peng D; Sun W
ANZ J Surg; 2023 Jun; 93(6):1551-1558. PubMed ID: 37226585
[TBL] [Abstract] [Full Text] [Related]
15. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell lung cancer: A Study Using Data from the Korean Nationwide lung cancer Registry.
Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
[TBL] [Abstract] [Full Text] [Related]
16. Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model.
Zhao M; Shao T; Chi Z; Tang W
Front Public Health; 2023; 11():1051484. PubMed ID: 36908446
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
[TBL] [Abstract] [Full Text] [Related]
18. Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in lung Squamous Cell Carcinoma.
Zhang H; AbdulJabbar K; Moore DA; Akarca A; Enfield KSS; Jamal-Hanjani M; Raza SEA; Veeriah S; Salgado R; McGranahan N; Le Quesne J; Swanton C; Marafioti T; Yuan Y
Cancer Res; 2023 May; 83(9):1410-1425. PubMed ID: 36853169
[TBL] [Abstract] [Full Text] [Related]
19. Applications of radiomics-based analysis pipeline for predicting epidermal growth factor receptor mutation status.
Liu Z; Zhang T; Lin L; Long F; Guo H; Han L
Biomed Eng Online; 2023 Feb; 22(1):17. PubMed ID: 36810090
[TBL] [Abstract] [Full Text] [Related]
20. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.
Dickson JL; Hall H; Horst C; Tisi S; Verghese P; Mullin AM; Teague J; Farrelly L; Bowyer V; Gyertson K; Bojang F; Levermore C; Anastasiadis T; McCabe J; Navani N; Nair A; Devaraj A; Hackshaw A; Quaife SL; Janes SM;
Lancet Public Health; 2023 Feb; 8(2):e130-e140. PubMed ID: 36709053
[TBL] [Abstract] [Full Text] [Related]
[Next]
